Search Results
Found 2 results
510(k) Data Aggregation
(64 days)
The Osmetech OPTI LION Electrolyte Analyzer is intended to be used for the measurement of pH, sodium, potassium, ionized calcium, and chloride in samples of whole blood, serum, plasma and aqueous controls in either a traditional clinical laboratory setting or point-of-care locations by personnel minimally qualified to perform and report these results.
The OPTI LION Electrolyte Analyzer is a small [4.7 x 14.2 x 9.1 inches, 10 pounds}, microprocessor-based instrument using optical fluorescence for the measurement of pH, sodium, potassium, ionized calcium, and chloride and utilizes a graphical touch screen user interface.
The disposable, single use cassette contains five optical fluorescent sensors placed in a polycarbonate substrate, which is packaged with an insert-able sample probe into a sealed foil pouch which bears a bar-code label with calibration, lot identification, and expiration dating information.
The Osmetech OPTI LION Electrolyte Analyzer is a medical device intended for the measurement of pH, sodium, potassium, ionized calcium, and chloride in whole blood, serum, plasma, and aqueous controls. The following information details the acceptance criteria and the study that proves the device meets these criteria.
1. Table of Acceptance Criteria and Reported Device Performance
The provided document does not explicitly state pre-defined acceptance criteria values for each analyte. Instead, it refers to the "medically allowable errors as defined in CLIA'88 performance standards" as the benchmark for comparison. The study's conclusion is that the device's performance is acceptable against these standards.
Without specific numerical acceptance criteria from the document, we can infer the performance metrics reported as evidence of meeting an unspecified acceptable level based on CLIA'88 standards.
| Analyte | Acceptance Criteria (Implied by CLIA'88 Standards) | Reported Device Performance (Systematic Differences and 95% CIs) |
|---|---|---|
| pH | Systematic differences and 95% CIs < Medically allowable errors (CLIA'88) | "lower than the medically allowable errors as defined in CLIA'88 performance standards" |
| Sodium | Systematic differences and 95% CIs < Medically allowable errors (CLIA'88) | "lower than the medically allowable errors as defined in CLIA'88 performance standards" |
| Potassium | Systematic differences and 95% CIs < Medically allowable errors (CLIA'88) | "lower than the medically allowable errors as defined in CLIA'88 performance standards" |
| Ionized Calcium | Systematic differences and 95% CIs < Medically allowable errors (CLIA'88) | "lower than the medically allowable errors as defined in CLIA'88 performance standards" |
| Chloride | Systematic differences and 95% CIs < Medically allowable errors (CLIA'88) | "lower than the medically allowable errors as defined in CLIA'88 performance standards" |
2. Sample Size for the Test Set and Data Provenance
The document states: "Specimens analyzed in these tests were remnant from patient specimens of both whole blood and plasma or serum collected for routine analysis on existing instrumentation." This indicates the data provenance is retrospective, using pre-existing patient samples. The country of origin of the data is not specified, but the applicant company is based in Roswell, GA, USA.
The exact sample size for the test set is not explicitly stated in the provided text.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
The document does not mention the use of experts to establish ground truth for the test set. Instead, the performance of the OPTI LION Electrolyte Analyzer was correlated against "predicate devices" in a clinical setting. This implies the "ground truth" was established by measurements from these predicate devices.
4. Adjudication Method for the Test Set
No adjudication method for the test set is mentioned. The comparison was made against predicate devices, which likely involved direct comparison of numerical results.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done
No, a Multi Reader Multi Case (MRMC) comparative effectiveness study was not done. The study focused on comparing the device's performance against predicate devices, not on human reader performance with or without AI assistance.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Yes, a standalone performance study was done. The "clinical testing was conducted to demonstrate the correlation of Osmetech OPTI LION Electrolyte Analyzer to predicate devices." This implies that the device (algorithm only, as it's an automated analyzer) was run on samples and its results were compared to those of existing predicate devices. The operation by "personnel minimally qualified to perform and report these results" indicates a human-in-the-loop for operation, but the performance being assessed is that of the analyzer itself.
7. The Type of Ground Truth Used
The ground truth used was established by measurements obtained from predicate devices. The document states, "Clinical testing was conducted to demonstrate the correlation of Osmetech OPTI LION Electrolyte Analyzer to predicate devices in a clinical setting." The "predicted systematic differences and their 95% confidence intervals between the OPTI LION and the predicated devices" were then compared to CLIA'88 performance standards.
8. The Sample Size for the Training Set
The document focuses on the validation of the device and does not provide information about a "training set" in the context of machine learning or AI models. This device is an analyzer that uses optical fluorescence and factory-calibrated cassettes, rather than an AI model that undergoes a training phase with a specific dataset. Therefore, the concept of a training set as typically understood for AI algorithms does not apply here, and no sample size for a training set is provided.
9. How the Ground Truth for the Training Set Was Established
Given that the device is an analyzer based on optical fluorescence and factory-calibrated cassettes, it does not have a "training set" in the AI sense. Its calibration is performed during manufacturing, and each cassette contains bar-coded calibration information.
The description of calibration states: "Each lot of OPTI LION cassettes is calibrated during the manufacturing process... The OPTI LION system uses a proprietary dry calibration process... This dry-to-wet (mid-physiologic) relationship is stable and consistent for all sensors in a lot, and is characterized and bar-coded at the factory. In addition, the sensor's wet response curve of the fluorescent intensity versus analyte level is factory-characterized and bar-coded."
Therefore, the "ground truth" for the device's operational parameters (akin to a training phase in AI) is established through factory characterization and calibration based on known concentrations of analytes and the relationship between dry and wet fluorescent intensities. This is an engineered calibration rather than a data-driven training process with human-established ground truth.
Ask a specific question about this device
(81 days)
The Roche Diagnostics Omni S Analyzer is a fully automated critical care analyzer intended to be used for the measurement of pH, PO2, PCO2, sodium, potassium, ionized calcium, chloride, hematocrit, glucose, lactate, urea/BUN, total hemoglobin, oxygen saturation, oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin in samples of whole blood, serum, plasma and aqueous solutions as appropriate.
The Omni S analyzer represents a combined pH, blood gas, electrolyte, glucose, lactate, urea/BUN, total hemoglobin, hemoglobin derivatives, hematocrit and oxygen saturation test system classified as a Class II device based on the individual test parameters measured.
The provided text is a 510(k) summary for the Roche Diagnostics Omni S Analyzer. It focuses on demonstrating substantial equivalence to predicate devices for regulatory clearance rather than detailing a specific study with acceptance criteria and performance metrics in the way a clinical trial report would.
Therefore, the information required to fully answer your request regarding acceptance criteria and the study that proves the device meets the acceptance criteria is not explicitly present in the provided document.
Here's what can be extracted and what is missing, based on the standard structure of your request:
1. Table of Acceptance Criteria and Reported Device Performance:
This information is not provided in the document. The 510(k) summary states that the Omni S Analyzer has "incorporated the same blood gas modules as utilized in the Omni Modular and Omni C analyzers," and "the same ISE modules," "the same tHb (total hemoglobin ) and SO2 (oxygen saturation) sensor," and "similar types of MSS sensors." This implies that the performance of the Omni S is expected to be substantially equivalent to the predicate devices, but specific numerical acceptance criteria or performance results for the Omni S are not presented.
2. Sample Size Used for the Test Set and Data Provenance:
This information is not provided in the document. While it mentions "samples of whole blood, serum, plasma and aqueous solutions," it does not specify the sample size used in any testing or the provenance (country, retrospective/prospective) of such data.
3. Number of Experts Used to Establish Ground Truth and Qualifications:
This information is not provided in the document. The device is a diagnostic analyzer for measuring various physiological parameters, and its ground truth would typically be established by reference methods or validated laboratory instruments, not necessarily through human expert consensus in the same way an imaging AI might.
4. Adjudication Method for the Test Set:
This information is not provided in the document. As mentioned above, the nature of the device's measurements would typically rely on instrument-based validation rather than human adjudication.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done:
No, an MRMC study was not done. This type of study is relevant for devices like imaging AI that assist human readers in interpretation. The Omni S Analyzer is a laboratory instrument that provides direct measurements, not an assistive AI for human interpretation.
6. If a Standalone Study Was Done:
The document implies that the device (Omni S Analyzer) was tested for its performance, as it leverages components from previous cleared devices. However, a detailed "standalone study" report with specific performance metrics (e.g., accuracy, precision, linearity) for the Omni S itself is not included in this 510(k) summary. The summary focuses on demonstrating substantial equivalence by comparing its components and intended use to existing, legally marketed devices.
7. The Type of Ground Truth Used:
While not explicitly stated for the Omni S, for such laboratory analyzers, the ground truth would typically be established by reference methods or by measurements obtained from validated predicate devices or established laboratory techniques known to be accurate.
8. The Sample Size for the Training Set:
This information is not applicable as the Omni S Analyzer is not an AI/ML device that requires a "training set" in the conventional sense. It's an automated analyzer based on established sensor technologies.
9. How the Ground Truth for the Training Set Was Established:
This information is not applicable for the same reason as point 8.
In summary:
This 510(k) summary is designed to demonstrate substantial equivalence to predicate devices, mainly by comparing the intended use, measured parameters, and the nature of the incorporated modules (e.g., "same blood gas modules," "similar types of MSS sensors"). It does not contain the detailed study results with acceptance criteria and performance metrics that would be part of a full validation report for the device.
Ask a specific question about this device
Page 1 of 1